MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Asivatrep

CAS No. : 1005168-10-4

MCE 站：Asivatrep

产品活性：Asivatrep (PAC-14028) 是高效的选择性的瞬时受体电位香草酸亚型1 (TRPV1) 拮抗剂。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling

作用靶点：TRP Channel

In Vitro: Asivatrep (PAC-14028) could prevent barrier damages, accelerate skin barrier recovery and suppress pruritus, showing a potential for the treatment of atopic dermatitis. It could suppress serum IgE increase, epidermal infiltration of inflammatory cells and mast cell degranulation associated with atopic dermatitis. Asivatrep (PAC-14028) shows efficacies against diverse disease models including visceral pain, inflammatory bowel disease, and inflammatory pain.

In Vivo: Asivatrep (PAC-14028) shows a plasma half-life of 2.1 h in rats while it is extended slightly to 3.8 h in minipigs. Oral bioavailability at 10 mg/kg dose is determined to be 52.7% and 64.2% in rats and minipigs, respectively suggesting that Asivatrep (PAC-14028) is relatively well-absorbed through oral route. Asivatrep (PAC-14028) could inhibit capsaicin-evoked calcium influx in keratinocytes at sub-micromolar concentrations. This potent TRPV1 antagonistic activity in keratinocytes is manifested in vivo as the blockade of capsaicin-induced blood perfusion increase, and the accelerated barrier recovery from tape-stripping-induced barrier damages in hairless mice.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Rosiglitazone  |  Capsaicin  |  Diphenyleneiodonium chloride  |  EIPA  |  Amiloride hydrochloride  |  Capsazepine  |  Probenecid  |  2-Aminoethyl diphenylborinate  |  GSK1016790A  |  SKF-96365 hydrochloride  |  HC-067047  |  BI-749327  |  AMG9810  |  GSK2193874  |  GSK205  |  N-(p-amylcinnamoyl) Anthranilic Acid  |  Icilin  |  Pyr3  |  Hydroxy-α-sanshool  |  RN-1734  |  PF-4840154  |  AMG 517  |  Caffeic acid  |  (-)-Menthol  |  Adenosine 5′-diphosphoribose sodium  |  SAR7334  |  BCTC

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。